Log in to your Inderes Free account to see all free content on this page.
Nanoform Finland
2.155 EUR +6.16%3,393 investors are following this company
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Revenue
2.57M
EBIT %
-874.71 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
NANOFH
Daily low / high price
2.01 / 2.175
EUR
Market cap
184.13M EUR
Turnover
401.81K EUR
Volume
195K
Latest videos
Financial calendar
Interim report
30.05.2024
Interim report
29.08.2024
Interim report
22.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Handelsbanken | 7.5 % | 7.5 % |
Edward Hæggström | 6.9 % | 6.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
New shares of Nanoform registered with the trade register
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio